Autopsy report · NCT05109650

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients

“Considering that the high budget will affect the subsequent development, it is decided to terminate the test voluntarily”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 1 year 11 months before it stopped.
• 13 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Bio-Thera Solutions

Sponsor type

Industry

Conditions

Advanced Solid Tumour

Interventions

BAT6026; BAT1308

Participants

13

Sites

3

Countries

Australia

Trials that died the same way

• A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
  “Voluntarily terminate the study since the sponsor's development strategy was adjusted.” (66% match in meaning)
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors（MEETCD8-001）
  “Due to adjustments in the sponsor's development strategy, it has been decided to terminate the study.” (63% match in meaning)
• Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis
  “Early termination due to operational feasibility reasons, resulting from a slow recruitment rate and logistical and financial difficulties that prevent reaching the planned sample size within the study schedule.” (61% match in meaning)
• Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome
  “Study stopped due to budget (personnel) limitations.” (60% match in meaning)
• Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)
  “The study was terminated as it was determined to not be feasible to complete enrollment and the study within the required timeline and budget.” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.